Skip to main content
Top

Drugs

Issue 1/2008

Content (9 Articles)

Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer

  • Current Opinion

Sarah J. Needleman, Jeffrey S. Tobias

Antiepileptic Drug Development in Children

  • Current Opinion

Catherine Chiron, Olivier Dulac, Gerard Pons

Nonresponse to Treatment for Hepatitis C

  • Therapy In Practice

He-Jun Yuan, William M. Lee

Antiretroviral Therapy

  • Review Article

Jorge L. Martinez-Cajas, Mark A. Wainberg

Pharmacological Treatment of Early Multiple Sclerosis

  • Review Article

Olaf Stüve, Jeffrey L. Bennett, Bernhard Hemmer, Heinz Wiendl, Michael K. Racke, Amit Bar-Or, Wei Hu, Robert Zivadinov, Martin S. Weber, Scott S. Zamvil, Maria F. Pacheco, Til Menge, Hans-Peter Hartung, Bernd C. Kieseier, Elliot M. Frohman

Sevelamer Hydrochloride

  • Adis Drug Evaluation

David R. Goldsmith, Lesley J. Scott, Risto S. Cvetković, Greg L. Plosker

Parnaparin

  • Adis Drug Evaluation

Kate McKeage, Gillian M. Keating

Diclofenac Sodium Injection (Dyloject®)

  • Adis Drug Profile

Paul L. McCormack, Lesley J. Scott

Raltegravir

  • Adis Drug Profile

Jamie D. Croxtall, Katherine A. Lyseng-Williamson, Caroline M. Perry

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images